Hls Therapeutics (TSE:HLS) has released an update.
HLS Therapeutics Inc., a pharmaceutical company specializing in psychiatric and cardiovascular treatments, will be featured at the Bloom Burton & Co. Healthcare Investor Conference. CEO Craig Millian is scheduled to present on April 17, 2024, with the event being webcasted online. Additionally, personal meetings with investors will be conducted by Millian and Interim CFO John Hanna during the conference.
For further insights into TSE:HLS stock, check out TipRanks’ Stock Analysis page.
